Emerging Therapies · Light Therapy
Effects of 660-nm Photobiomodulation Therapy on Pain and Healing of Nipple Trauma in Lactating Women: A Pilot Randomized Double-Blind Controlled Trial
Moraes BHM et al., 2026 Preprint
929 works
Therapeutics
The medication classes used in restorative care, with their mechanisms, monitoring, and evidence.
In Therapeutics
929 works
Metabolic and Endocrine Agents · GLP-1 Receptor Agonists
Evidence That Semaglutide Represents an Important Tool for Treatment of Irregular Menses and Chronic Anovulation in Women with Polyendocrine Metabolic Ovarian Syndrome
Carmina E et al., 2026
Metabolic and Endocrine Agents · GLP-1 Receptor Agonists
GLP-1 Receptor Agonists and Fertility: What Is Known So Far?
Becker AS et al., 2026
Emerging Therapies · Light Therapy
630 nm LED phototherapy enhances ovarian function and fertility potential in advanced reproductive age females
Su T et al., 2026
Hormonal Agents · Progesterone and Progestins
Intravaginal progesterone as a fertility-sparing treatment for symptomatic adenomyosis: preliminary results from a monocentric study
De Cicco Nardone C et al., 2026
Supplements and Botanicals · Antioxidant Supplements
Alpha-Lipoic Acid and Leucine as Adjunct Therapy for Persistent First-Trimester Subchorionic Hematomas in Assisted Reproductive Technology Pregnancies
Bano T et al., 2026
Emerging Therapies · Platelet-Rich Plasma
Platelet-rich plasma in the management of vulvovaginal disorders: a systematic review
De Ponte A et al., 2026
Hormonal Agents · Estrogen Preparations
Risk and management of congenital thrombophilia in transgender individuals undergoing gender-affirming hormone therapy
Campello E et al., 2026
Hormonal Agents · Androgens and DHEA
Cardiovascular safety of testosterone therapy-Insights from the TRAVERSE trial and beyond: A position statement of the European Expert Panel for Testosterone Research
Zitzmann M et al., 2026
Ovulation Agents · Selective Estrogen Receptor Modulators
Signal Detection and Pharmacovigilance Analysis of Tamoxifen, Clomiphene, and Letrozole in Polycystic Ovarian Syndrome: A FAERS Database Study
Zhang D et al., 2026
Metabolic and Endocrine Agents · GLP-1 Receptor Agonists
Balancing metabolic optimization and reproductive safety in Polycystic Ovary Syndrome: a Bayesian-informed framework for GLP-1 receptor agonists
Song E et al., 2026
Hormonal Agents · Progesterone and Progestins
SUN-109 Feasibility of Cyclic Progesterone and Spironolactone for PCOS-specific Health-Related Quality of Life—a six-month, Phase II, single arm, single center, open-label study
Nelson K et al., 2025
Emerging Therapies · Light Therapy
Photobiomodulation in Complex Female Infertility Profile: A Case Report with 12-Month Follow-Up and Review of Current Mechanism in Reproductive Photomedicine
Phypers R et al., 2025
Hormonal Agents · Estrogen Preparations
The Chronobiology of Hormone Administration: "Doctor, What Time Should I Take My Medication?"
Colonnello E et al., 2025
Hormonal Agents · Progesterone and Progestins
Factors Affecting Hormonal Therapy Ineffectiveness and Discontinuation due to Adverse Effects in Patients with Endometriosis-Associated Pain
Fayek B et al., 2025
Emerging Therapies · Platelet-Rich Plasma
Spontaneous pregnancy following intra-ovarian platelet-rich plasma administration in poor ovarian responders according to the POSEIDON criteria: A cross-sectional study
Sanuie Farimani M et al., 2025
